Yes and no.
If you understand how it works (and this is common to the cause of cardiotoxicity in other drugs) then there is a better chance of knowing what to target, saving cost and time.
But as you say clinical results and efficacy are what matters at the end of the day.
Does knowing that Zantrene works as an FTO inhibitor simply ‘nice to know’?
Yes and no.If you understand how it works (and this is common to...
-
- There are more pages in this discussion • 4,951 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.030(2.10%) |
Mkt cap ! $238.5M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.46 | $1.38 | $123.1K | 87.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19987 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 330 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |